Company Filing History:
1 out of 23 
1 out of 270 
Years Active: 2021
Title: Michelle Ehrlich: Innovator in Stem Cell Research
Introduction
Michelle Ehrlich is a prominent inventor based in New York, NY, known for her significant contributions to stem cell research. She has developed innovative methods for generating basal forebrain cholinergic neurons (BFCNs) from stem cells, which hold promise for treating Alzheimer's disease. Her work is particularly focused on addressing electrophysiological defects related to mutations in PSEN2.
Latest Patents
Michelle Ehrlich holds one patent titled "Method and composition for generating basal forebrain cholinergic neurons (BFCNs)." This invention relates to the development of BFCNs from stem cells, specifically targeting those with repaired electrophysiological defects. The potential applications of her invention in cell-based therapies for Alzheimer's disease highlight its importance in the field of neuroscience.
Career Highlights
Throughout her career, Michelle has worked with esteemed organizations such as the New York Stem Cell Foundation, Inc. and the Icahn School of Medicine at Mount Sinai. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community significantly.
Collaborations
Michelle has collaborated with notable colleagues, including Scott Noggle and Maitane Ortiz-Virumbrales. These partnerships have further enriched her research and expanded the impact of her work in the field of stem cell therapy.
Conclusion
Michelle Ehrlich's innovative work in stem cell research and her patent for generating basal forebrain cholinergic neurons mark her as a key figure in the fight against Alzheimer's disease. Her contributions continue to inspire advancements in medical science and therapy.